Gilead Sciences (GILD) Change in Cash (2009 - 2026)

Gilead Sciences has reported Change in Cash for 18 years, with the latest figure at $65.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 103.15% year-over-year to $65.0 million; the trailing twelve-month figure through Mar 2026 stood at -$298.0 million (down 109.29% YoY), and the FY2025 full-year result was -$2.4 billion, down 162.16% from the prior year.
• Change in Cash for Q1 2026 stood at $65.0 million, down from $233.0 million in the prior quarter.
• The five-year high for Change in Cash was $5.0 billion in Q4 2024, with the low at -$2.8 billion in Q2 2025.
• Historically, Change in Cash has averaged $134.7 million across 5 years, with a median of $65.0 million in 2026.
• The largest YoY upside for Change in Cash was 226300.0% in 2024 against a maximum downside of 353.39% in 2024.
• Gilead Sciences' Change in Cash stood at $713.0 million in 2022, then plunged by 46.7% to $380.0 million in 2023, then surged by 1203.95% to $5.0 billion in 2024, then slumped by 95.3% to $233.0 million in 2025, then tumbled by 72.1% to $65.0 million in 2026.
• The last three Change in Cash figures came in at $65.0 million (Q1 2026), $233.0 million (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.